Found: 11
Select item for more details and to access through your institution.
Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19".
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 11, p. 2463, doi. 10.1007/s40121-024-01054-6
- By:
- Publication type:
- Article
Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 11, p. 2377, doi. 10.1007/s40121-024-01046-6
- By:
- Publication type:
- Article
Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 8, p. 1821, doi. 10.1007/s40121-024-01010-4
- By:
- Publication type:
- Article
Comparison of the Effectiveness of Baloxavir and Oseltamivir in Outpatients With Influenza B.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 9, p. 1, doi. 10.1111/irv.70002
- By:
- Publication type:
- Article
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13302
- By:
- Publication type:
- Article
Reconstructing the household transmission of influenza in the suburbs of Tokyo based on clinical cases.
- Published in:
- Theoretical Biology & Medical Modelling, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12976-021-00138-x
- By:
- Publication type:
- Article
Patient journey through cases of depression from claims database using machine learning algorithms.
- Published in:
- PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0247059
- By:
- Publication type:
- Article
Comparison of Hospitalization Incidence in Influenza Outpatients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 5, p. e1181, doi. 10.1093/cid/ciaa1870
- By:
- Publication type:
- Article
Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. e859, doi. 10.1093/cid/ciaa1622
- By:
- Publication type:
- Article
Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 2, p. 992, doi. 10.1007/s12325-021-02008-x
- By:
- Publication type:
- Article
Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 379, doi. 10.1007/s12325-021-01965-7
- By:
- Publication type:
- Article